Innoviva (INVA) Short term Debt (2010 - 2025)
Innoviva's (INVA) quarterly Short term Debt came in at $191.9 million in Q2 2025, little changed on a QoQ basis from $192.2 million in Q1 2025.
Analysis
Innoviva (INVA) Short term Debt (2010 - 2025) Analysis & Trends
Innoviva (INVA) has 10 years of Short term Debt data on file, last reported at $191.9 million in Q2 2025.
- Quarterly Short term Debt changed N/A year-over-year to $191.9 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $191.9 million (changed N/A YoY) and the FY2024 annual result came in at $192.0 million, changed N/A from the prior year.
- Short term Debt held at $191.9 million in Q2 2025, from $192.2 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $192.2 million in Q1 2025 to a low of $96.0 million in Q1 2022.
- A 3-year average of $144.1 million and a median of $144.0 million in 2022 frame the typical range for Short term Debt.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 191.90 Mn |
| Mar 31, 2025 | 192.22 Mn |
| Dec 31, 2024 | 192.03 Mn |
| Sep 30, 2024 | 191.84 Mn |
| Dec 31, 2022 | 96.19 Mn |
| Sep 30, 2022 | 96.13 Mn |
| Jun 30, 2022 | 96.07 Mn |
| Mar 31, 2022 | 96.02 Mn |
| Dec 31, 2017 | 25.00 Mn |
| Sep 30, 2017 | 25.00 Mn |
| Jun 30, 2017 | 15.18 Mn |
| Mar 31, 2017 | 6.70 Mn |
| Dec 31, 2016 | 7.75 Mn |
| Sep 30, 2016 | 3.55 Mn |
| Jun 30, 2016 | 3.27 Mn |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | 69,000.00 |
| Sep 30, 2011 | 109,000.00 |
| Jun 30, 2011 | 162,000.00 |
| Dec 31, 2010 | 206,000.00 |